‘Rollover’ abdominal paracentesis versus standard technique: protocol of a crossover randomized comparative trial

Author:

Sharma Vishal1ORCID,Jha Daya Krishna1ORCID,Rohilla Manish2ORCID,Das Chandan K3ORCID,Singh Harjeet4ORCID,Irrinki Santhosh4ORCID,Arora Aashima5ORCID,Saha Subhas C5,Gupta Pankaj6,Mandavdhare Harshal S1ORCID,Dutta Usha1ORCID,Sharma Aman7ORCID

Affiliation:

1. Department of Gastroenterology, Postgraduate Institute of Medical Education & Research, Chandigarh, 160012, India

2. Department of Cytopathology, Postgraduate Institute of Medical Education & Research, Chandigarh, 160012, India

3. Department of Medical Oncology, Postgraduate Institute of Medical Education & Research, Chandigarh, 160012, India

4. Department of Surgical Gastroenterology, Postgraduate Institute of Medical Education & Research, Chandigarh, 160012, India

5. Department of Obstetrics & Gynecology, Postgraduate Institute of Medical Education & Research, Chandigarh, 160012, India

6. Department of Radiodiagnosis, Postgraduate Institute of Medical Education & Research, Chandigarh, 160012, India

7. Department of Internal Medicine, Postgraduate Institute of Medical Education & Research, Chandigarh, 160012, India

Abstract

The sensitivity of single abdominal paracentesis for diagnosis of peritoneal carcinomatosis in patients with malignant ascites is 40–70%. Tumor cells shed from the peritoneum settle preferentially in certain recesses of the peritoneum. We aim to compare the standard technique of abdominal paracentesis versus a rollover technique in a randomized crossover study to assess the cytological yield in patients suspected to have peritoneal carcinomatosis. Each patient will serve as their own control and the outcome assessor (cytopathologist) will be blinded to the method of paracentesis performed. The primary objective will be to compare the tumor cell positivity between the standard paracentesis group and the rollover group among enrolled patients. Clinical Trial registration: CTRI/2020/06/025887 and NCT04232384 .

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3